18th Apr 2005 16:46
GlaxoSmithKline PLC18 April 2005 Director's Interests I give below details of changes in directors' interests in the Ordinary Sharesof GlaxoSmithKline plc. 15 April 2005 The Administrators of the SmithKline Beecham Employee Benefit Trust ("the Trust") notified the Company on 18 April 2005 that following reinvestment of the cash dividend paid to shareholders on 07 April 2005, 1,228 Ordinary Shares in the Company had been purchased for participants in the SmithKline Beecham Bonus Investment Plan at a price of £12.747 per share. 15 April 2005 The Administrators of the Trust also notified the Company on 18 April 2005 that following reinvestment of the cash dividend paid to shareholders on 07 April 2005, 8,702 Ordinary Shares in the Company had been purchased for participants in the GlaxoSmithKline Annual Investment Plan at a price of £12.747 per share. The Trust is a discretionary fund of which all non US employees or formeremployees of GlaxoSmithKline plc and its subsidiaries are potentialbeneficiaries. One of the Company's directors, Julian Heslop is thereforeinterested in the shares held in the fund from time to time in the same way asother non US employees or former employees of GlaxoSmithKline plc and itssubsidiaries. S M BicknellCompany Secretary 18 April 2005 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Glaxosmithkline